Winton Capital »

Indivior Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 205k 30.48

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ge Vernova (GEV)
Booking Holdings (BKNG)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
CSX Corporation (CSX)
Solstice Advanced Matls Com Shs (SOLS)
Kroger (KR)
AES Corporation (AES)
Entegris (ENTG)
Electronic Arts (EA)
Hologic
Masimo Corporation (MASI)
Stifel Financial (SF)

View all positions for Winton Capital

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals